Pathways to heroin dependence: Time to re-appraise self-medication

Addiction

Volumn 108, Issue 4, 2013, Pages 659-667

  Darke, Shane ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Heroin; Psychopathology; Self medication; Theory

Indexed keywords

ADULT; CHILD; COMPLICATION; DISEASE COURSE; GENETICS; HEROIN DEPENDENCE; HUMAN; MENTAL STRESS; PSYCHOLOGY; RISK FACTOR; SELF MEDICATION; PSYCHOLOGICAL ASPECT; REVIEW;

ADULT; CHILD; DISEASE PROGRESSION; HEROIN DEPENDENCE; HUMANS; RISK FACTORS; SELF MEDICATION; STRESS, PSYCHOLOGICAL;

EID: 84876360703     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2012.04001.x     Document Type: Article

References (103)

1. West R., Hardy A. Theory of Addiction. London: Blackwell Publishing; 2006.
2. Khantzian E.J. Psychological (structural) vulnerabilities and the specific appeal of narcotic. Ann NY Acad Sci 1982; 398: 24-32.
3. Khantzian E.J. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry 1985; 142: 1259-64.
4. Khantzian E.J. Addiction: self-destruction or self-repair? J Subst Abuse Treat 1989; 6: 75.
5. Khantzian E.J. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harvard Rev Psychiatry 1997; 4: 231-44.
6. Khantzian E.J. Treating Addiction as a Human Process. Northvale: Jason Aronson; 1999.
7. Khantzian E.J., Albernese M. J. Understanding Addiction as Self-Medication. Finding Hope Behind the Pain. Lanham: Rowman and Littlefield; 2008.
8. Khantzian E.J., Mack J. E., Schatzberg A. F. Heroin use as an attempt to cope: clinical observations. Am J Psychiatry 1974; 131: 160-4.
9. Khantzian E.J., Schneider R. J. Treatment implications of a psychodynamic understanding of opioid addicts. In: Meyer R. E., editor. Psychopathology and Addictive Disorders. New York: Guilford Press; 1986, p. 323-33.
10. DuPont R. L., Gold M. S. Comorbidity and 'selfmedication'. J Addict Dis 2007; 26: 13-23.
11. Goldsmith R. J. An integrated psychology for the addictions: beyond the self-medication hypothesis. J Addict Dis 1993; 12: 139-54.
12. Vaillant G. R. E., Milofsky E. S. The etiology of alcoholism: a prospective viewpoint. Am Psychol 1982; 37: 494- 503.
13. Darke S. The Life of the Heroin User: Typical Beginnings, Trajectories and Outcomes. Cambridge: Cambridge University Press; 2011.
14. United Nations Office of Drug Control. World Illicit Drug Report 2011. New York: United Nations Publications; 2011.
15. Blume A., Schmaling K., Marlatt G. Revisiting the selfmedication hypothesis from a behavioral perspective. Cogn Behav Pract 2000; 7: 379-84.
16. Graham H., Power C. Childhood disadvantage and health inequalities: a framework for policy based on lifecourse research. Child Care Health Dev 2004; 30: 671-8.
17. Wilkinson R., Marmot M., editors. The Solid Facts: Social Determinants of Health. 2nd edn Copenhagen: Centre for Urban Health World Health Organization; 2003.
18. Galea S., Nandi V. V., Vlahov D. The social epidemiology of substance use. Epidemiol Rev 2004; 26: 36-52.
19. Poulton R., Caspi A., Milne B. J., Thomson W. M., Taylor A., Sears M. R. et al. Association between children's experience of socioeconomic disadvantage and adult health: a life-course study. Lancet 2002; 360: 1640-5.
20. Darke S., Ross J. The relationship between suicide and overdose among methadone maintenance patients in Sydney, Australia. Addiction 2001; 96: 1443-53.
21. Conroy E., Degenhardt L., Mattick R., Nelson E. C. Child maltreatment as a risk factor for opioid dependence: comparison of family characteristics and type and severity of child maltreatment with a matched control group. Child Abuse Negl 2009; 33: 343-52.
22. Coviello D. M., Alterman A. I., Cacciola J. S., Rutherford M. J., Zanis D. A. The role of family history in addiction severity and treatment response. J Subst Abuse Treat 2004; 26: 1-11.
23. Hser Y. Predicting long-term stable recovery from heroin addiction: findings from a 33-year follow-up. J Addict Dis 2007; 26: 51-60.
24. Rossow I., Lauritzen G. Shattered childhood: a key issue in suicidal behavior among drug addicts. Addiction 2001; 96: 227-40.
25. Ravndal E., Lauritzen G., Jansson S. O., Larsson J. Childhood maltreatment among Norwegian drug abusers in treatment. Int J SocWelfare 2001; 10: 142-7.
26. Fergusson D. M., Horwood L. J., Lynskey M. T. Parental separation. Adolescent psychopathology, and problem behaviors. J Am Acad Child Adolesc Psychiatry 1994; 338: 1122-31.
27. Lipman E. L., Boyle M. H., Dooley M. D., Offord D. R. Child well-being in single mother families. J Am Acad Child Adolesc Psychiatry 2002; 41: 75-82.
28. Heffernan K., Cloitre M., Tardiff K., Marzuk P., Portera L., Leon A. Childhood trauma as a correlate of lifetime opiate use in psychiatric patients. Addict Behav 2000; 25: 797- 803.
29. Ompad D. C., Ikeda R. M., Shah N., Fuller C. M., Bailey S., Morse E. et al. Childhood sexual abuse and age at initiation of injection drug use. Am J Public Health 2005; 95: 703-9.
30. Westermeyer J., Wahmanholm K., Thuras P. Effects of childhood physical abuse on course and severity of substance abuse. Am J Addict 2001; 10: 101-10.
31. Wu N. S., Schairer L. C., Dellor E., Grell C. Childhood trauma and health outcomes in adults with comorbid substance abuse and mental health disorders. Addict Behav 2010; 35: 68-71.
32. Braitstein P., Lia K., Tyndall M., Spittal P., O'Shaughnessy M. V., Schilder A. et al. Sexual violence among a cohort of injection drug users. Soc Sci Med 2003; 57: 561-9.
33. Gilbert L., El-Bassel N., Schilling R. F., Friedman E. Childhood abuse as a risk for partner abuse among women in methadone maintenance. Am J Drug Alcohol Abuse 1997; 23: 581-95.
34. Fergusson D. M., Lynskey M. T. Physical punishment/ maltreatment during childhood and adjustment in young adulthood. Child Abuse Negl 1997; 21: 617-30.
35. Knutson J., DeGarmo D., Reid J. Social disadvantage and neglectful parenting as precursors to the development of antisocial and aggressive child behavior: testing a theoretical model. Aggress Behav 2004; 30: 187-205.
36. Bartholomew N. G., Courtney K., Rowan-Szal G. A., Simpson D. D. Sexual abuse history and treatment outcomes among women undergoing methadone treatment. J Subst Abuse Treat 2005; 29: 231-5.
37. Branstetter S. A., Bower E. H., Kamien J., Amass L. A history of sexual, emotional, or physical abuse predicts adjustment during opioid maintenance treatment. J Subst Abuse Treat 2008; 34: 208-14.
38. Oviedo-Joekes E., Marchand K., Guh D., Marsh D. C., Brissettte S., Krausz M. et al. History of reported sexual or physical abuse among long-term heroin users and their response to substitution treatment. Addict Behav 2011; 36: 55-60.
39. Sansone R. A., Whitecar P., Wiederman M. W. The prevalence of childhood trauma among those seeking buprenorphine treatment. J Addict Dis 2009; 28: 64-7.
40. Ahmadi J., Arabi H., Mansouri Y. Prevalence of substance use among offspring of opioid addicts. Addict Behav 2003; 28: 591-5.
41. Darke S., Ross J., Lynskey M. The relationship of conduct disorder to attempted suicide and drug use history among methadone maintenance patients. Drug Alcohol Rev 2003; 22: 21-5.
42. Hahesy A. L., Wilens T. E., Biederman J., Van Patten S. L., Spencer T. Temporal association between childhood psychopathology and substance use disorders: findings from a sample of adults with opioid or alcohol dependency. Psychiatry Res 2002; 109: 245-53.
43. Lynskey M. T., Fergusson D. Childhood conduct problems, attention deficit behaviors, and adolescent alcohol, tobacco, and illicit drug use. J Abnorm Child Psychol 1995; 23: 281-301.
44. Pugatch D., Strong L. L., Has P., Patterson D., Combs C., Reinert R. et al. Heroin use in adolescents and young adults admitted for drug detoxification. J Subst Abuse 2001; 13: 337-46.
45. Wilens T. E., Biedeman J., Bredin E., Hahesy A. L., Abratntes A., Neft D. et al. A family study of the high-risk children of opioid- and alcohol-dependent parents. Am J Addict 2002; 11: 41- 51.
46. Brooner R. K., Greenfield L., Schmidt C. W., Bigelow G. E. Antisocial personality disorder and HIV infection in drug abusers. Am J Psychiatry 1993; 150: 53-8.
47. Darke S., Williamson A., Ross J., Teesson M., Lynskey M. Borderline personality disorder, antisocial personality disorder and risk-taking among heroin users: findings from the Australian Treatment Outcome Study (ATOS). Drug Alcohol Depend 2004; 74: 77-83.
48. Rouser E., Brooner R. K., Regier M. W., Bigelow G. E. Psychiatric distress in antisocial drug abusers: relation to other personality disorders. Drug Alcohol Depend 1994; 34: 149-54.
49. Gossop M., Marsden J., Stewart D., Treacy S. Change and stability of change after treatment of drug misuse. 2 year outcomes from the National Treatment Outcome Research Study. Addict Behav 2002; 27: 155-66.
50. Ross J., Teesson M., Darke S., Lynskey M., Ali R., Ritter A. et al. The characteristics of heroin users entering treatment: findings from the Australian Treatment Outcome Study (ATOS). Drug Alcohol Rev 2005; 24: 411-8.
51. Bargagli A. M., Faggiano F., Amato L., Salamina G., Davoli M., Mathis F. et al. VEdeTTE, a longitudinal study on effectiveness of treatments for heroin addiction in Italy: study protocol and characteristics of study population. Subst Use Misuse 2006; 41: 1861-79.
52. Brugal M. T., Barrio G., Fuente L., Regidor E., Royuela L., Suelves J. M. Factors associated with non-fatal heroin overdose: assessing the effect of frequency and route of heroin administration. Addiction 2002; 97: 319- 27.
53. Darke S., Williamson A., Ross J., Teesson M. Reductions in heroin use are not associated with increases in other drug use: two year findings from the Australian Treatment Outcome Study. Drug Alcohol Depend 2006; 84: 201-5.
54. Darke S., Ross J., Mills K., Teesson M., Williamson A., Havard A. Benzodiazepine use amongst heroin users: baseline use, current use and clinical outcome. Drug Alcohol Rev 2010; 29: 250-5.
55. Flynn P. M., Joe G.W., Broome K. M., Simpson D. D., Brown B. S. Recovery from opioid addiction in DATOS. J Subst Abuse Treat 2003; 25: 177-86.
56. Haasen C., Verthein U., Degkwitz P., Berger J., Krausz M., Naber D. Heroin-assisted treatment for opioid dependence randomised controlled trial. Br J Psychiatry 2007; 191: 55-62.
57. Hubbard R. L., Craddock S. G., Flynn P. M., Anderson J., Etheridge R. M. Overview of one year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychol Addict Behav 1997; 11: 261-78.
58. Miller C. L., Kerr T., Strathdee S. A., Li K.,Wood E. Factors associated with premature mortality among young injection drug users in Vancouver. Harm Reduct J 2007; 4: 1-7.
59. Quan V., Vongchak T., Jittiwutikan J., Kawichai S., Srirak N.,Wiboonnatakul K. et al. Predictors of mortality among injecting and non-injecting HIV-negative drug users in northern Thailand. Addiction 2007; 102: 441-6.
60. Williamson A., Darke S., Ross J., Teesson M. Effect of baseline cocaine use on treatment outcomes for heroin dependence over 24 months. J Subst Abuse Treat 2007; 33: 287-93.
61. Cacciola J. S., Alterman A. I., Rutherford M. J., McKay J. R., Mulvaney F. D. The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients. Drug Alcohol Depend 2001; 61: 271-80.
62. Lofwall M. R., Brooner R. K., Bigelow G. E., Kindbom K., Strain E. C. Characteristics of older opioid maintenance patients. J Subst Abuse Treat 2005; 28: 265-72.
63. Darke S., Ross J., Williamson A., Mills K. L., Havard A., Teesson M. Patterns of non-fatal heroin overdose over a three year period: findings from the Australian Treatment Outcome Study. J Urban Health 2007; 84: 283-91.
64. Brienza R. S., Stein M. D., Chen M. H., Cogineni A., Sobota M., Maksad J. et al. Depression among needle exchange and methadone maintenance clients. J Subst Abuse Treat 2000; 18: 331-7.
65. Darke S., Ross J. Polydrug dependence and psychiatric comorbidity among heroin injectors. Drug Alcohol Depend 1997; 48: 135-41.
66. Kidorf M., Disney E. R., King V. L., Neufeld K., Beilenson P. L., Brooner R. K. Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program. Drug Alcohol Depend 2004; 74: 115-22.
67. Maloney E., Degenhardt L., Darke S., Nelson E. C. Investigating the co-occurrence of self-mutilation and suicide attempts among opioid dependent individuals. Suicide Life Threat Behav 2010; 40: 50-62.
68. Teesson M., Havard A., Fairbairn S., Ross J., Lynskey M., Darke S. Depression among entrants to treatment for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence, correlates and treatment seeking. Drug Alcohol Depend 2005; 78: 309- 15.
69. Dore G., Mills K., Murray R., Teesson M., Farrugia P. Post-traumatic stress disorder, depression and suicidality in inpatients with substance use disorders. Drug Alcohol Rev 2012; 33: 294-302.
70. Hien D. A., Jiang H., Campbell A. N. S., Hu M., Miele G. M., Cohen L. R. et al. Do treatment improvements in PTSD severity affect substance use outcomes? A secondary analysis from a randomized clinical trial in NIDA's Clinical Trials Network. Am J Psychiatry 2010; 167: 95-101.
71. Hien D. A., Nunes E., Levin F. R., Fraser D. Posttraumatic stress disorder and short-term outcome in early methadone treatment. J Subst Abuse Treat 2000; 19: 31-7.
72. Mills K., Lynskey M., Teesson M., Ross J., Darke S. Posttraumatic stress disorder among people with heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence and correlates. Drug Alcohol Depend 2005; 77: 243-9.
73. Kessler R. C., Berglund P., Demler O., Jin R., Merikangas K. R., Walters E. E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey replication. Arch Gen Psychiatry 2005; 62: 593-602.
74. Darke S., Ross J., Williamson A., Mills K. L., Havard A., Teesson M. Patterns and correlates of attempted suicide by heroin users over a three year period: findings from the Australian Treatment Outcome Study. Drug Alcohol Depend 2007; 87: 146-52.
75. Rossow I., Lauritzen G. Balancing on the edge of death: suicide attempts and life-threatening overdoses among drug addicts. Addiction 1999; 94: 209-19.
76. Roy A. Characteristics of opiate dependent patients who attempt suicide. J Clin Psychiatry 2002; 63: 403-7.
77. Roy A. Risk factors for attempting suicide in heroin addicts. Suicide Life Threat Behav 2010; 40: 416-20.
78. Trémeau F., Darrey A., Staner L., Corrêa H., Weibel H., Khidichian F. et al. Suicidality in opioid-dependent subjects. Am J Addict 2008; 17: 187-94.
79. Borges G., Walters E. E., Kessler R. C. Associations of substance use, abuse, and dependence with subsequent suicidal behaviour. Am J Epidemiol 2000; 151: 781-9.
80. Johnston A., Pirkis J., Burgess P. M. Suicidal thoughts and behaviours among Australian adults: findings from the 2007 National Survey of Mental Health and Wellbeing. Aust NZ J Psychiatry 2009; 43: 635-43.
81. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Text revision. Washington, DC: American Psychiatric Association; 2000.
82. Trull T. J., Sher K. J., Minks-Brown C., Durbin J., Burr R. Borderline personality disorder and substance use disorders: a review and integration. Clin Psychol Rev 2000; 20: 235-53.
83. Teesson M., Mills K. L., Ross J., Darke S., Williamson A., Havard A. The impact of treatment on 3 year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS). Addiction 2008; 103: 80-8.
84. Havard A., Teesson M., Darke S., Ross J. Depression among heroin users: 12 month outcomes from the Australian Treatment Outcome Study (ATOS). J Subst Abuse Treat 2006; 30: 355-62.
85. Kandel D. B., editor. Stages and Pathways of Drug Involvement: Examining the Gateway Hypothesis. Cambridge: Cambridge University Press; 2002.
86. DeMaria P. A., Sterling R., Weinstein S. P. The effect of stimulant and sedative use on treatment outcome of patients admitted to methadone maintenance treatment. Am J Addict 2000; 9: 145-53.
87. Chilcoat H. D., Breslau N. Investigations of causal pathways between PTSD and drug use disorders. Addict Behav 1998; 23: 827-40.
88. Martins S. S., Keyes K. M., Storr C. L., Zhu H., ChilcoatH. D. Pathways between nonmedical opioid use/dependence and psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend 2009; 103: 16-24.
89. Back S. E., Brady K. T., Jaanimagi U., Jackson J. L. Cocaine dependence and PSTD: a pilot study of symptoms interplay and treatment preferences. Addict Behav 2006; 31: 351-4.
90. Back S. E., Brady K. T., Sonne S. C., Verduin M. L. Symptom improvement and co-occurring PTSD and alcohol dependence. J Nerv Ment Dis 2006; 194: 690-6.
91. Read J. P., Brown P. J., Kahler C. W. Substance use and posttraumatic stress disorders: symptoms interplay and effects on outcome. Addict Behav 2004; 29: 1665-72.
92. Plotzker R. E., MetzgerD. S., HolmesW. C. Childhood sexual and physical abuse histories, PTSD, depression, and HIV risk outcomes in women injection drug users: a potential mediating pathway. Am J Addict 2007; 16: 431-8.
93. Gottdiener W. H., Murawski P., Kucharski L. T. Using the delay discounting test for failures in ego control in substance users: a meta-analysis. Psychoanal Q 2008; 25: 533-49.
94. Chapman C., Mills K. L., Slade T., McFarlane A., Brysant R., Creamer M. et al. Remission from post-traumatic stress disorder in the general population. Psychol Med 2012; 42: 1695-1703.
95. Pietrzaka R. H., Goldstein R. B., Southwick S. M., Grant B. F. Prevalence and Axis I comorbidity of full and partial posttraumatic stress disorder in the United States: results from Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions. J Anx Dis 2011; 25: 456-65.
96. Agrawal A., Lynskey M. Are there genetic influences on addiction: evidence from family, adoption and twin studies. Addiction 2008; 103: 1069-81.
97. Clarke T. K., Krause K., Li T., Schumann G. An association of prodynorphin polymorphisms and opioid dependence in females in a Chinese population. Addict Biol 2009; 14: 366-70.
98. De los Cobos J. P. Association of CYP2D6 ultrarapid metabolizer genotype with deficient patient satisfaction regarding methadone maintenance treatment. Drug Alcohol Depend 2007; 89: 190-4.
99. Haile C. N., Kosten T. A., Kosten T. R. Pharmacogenetic treatments for drug addiction: alcohol and opiates. Am J Drug Alcohol Abuse 2008; 34: 355-81.
100. Mayer P., Hollt V. Pharmacogenetics of opioid receptors and addiction. Pharmacogenet Genomics 2006; 16: 1-7.
101. Tyrfingsson T., Thorgeirsson T. E., Geller F., Runarsdóttir V., Hansdóttir I., Bjornsdottir G. et al. Addictions and their familiality in Iceland. Ann NY Acad Sci 2010; 1187: 208- 17.
102. Rutter M., Bishop D. V., Pine D. S., Scott S., Stevenson J., Taylor E. et al. editors. Rutter's Child and Adolescent Psychiatry, 5th edn. Boston: Blackwell Publishing; 2008.
103. Degenhardt L., Chiu W. T., Conway K., Dierker L., Glantz M., Kalaydjian A. et al. Does the 'gateway' matter? Associations between the order of drug use initiation and the development of drug dependence in the National Comorbidity Study Replication. Psychol Med 2009; 39: 157-67.